Acute inflammation promotes early cellular stimulation of the epithelial and stromal compartments of the rat prostate

Prostate

Volumn 70, Issue 11, 2010, Pages 1153-1165

  Quintar, Amado A ^a   Doll, Andreas ^b   Leimgruber, Carolina ^a   Palmeri, Claudia M ^a   Roth, Felix D ^a   Maccioni, Mariana ^a   Maldonado, Cristina A ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Bacterial infection; Cell stimulation; Proliferation; Prostate inflammation; Smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTATIC BINDING PROTEIN; PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ACTIN; EGFR PROTEIN, RAT; PEBP1 PROTEIN, HUMAN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ESCHERICHIA COLI; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATITIS; RAT; SMOOTH MUSCLE FIBER; STROMA; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL GROWTH; ELECTRON MICROSCOPY; EPITHELIUM CELL; ESCHERICHIA COLI INFECTION; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; PROSTATE; STROMA CELL; WISTAR RAT;

ACTINS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL GROWTH PROCESSES; EPITHELIAL CELLS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICROSCOPY, ELECTRON; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROSTATE; PROSTATITIS; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77955938650     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21150     Document Type: Article

References (58)

1. Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007;51(5):1202-1216.
2. De Marzo AM, Platz EA, Sutcliffe S, Xu J, Gronberg H, Drake CG, Nakai Y, Isaacs WB, Nelson WG. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7(4):256-269.
3. Millan-Rodriguez F, Palou J, Bujons-Tur A, Musquera-Felip M, Sevilla-Cecilia C, Serrallach-Orejas M, Baez-Angles C, Villavicencio-Mavrich H. Acute bacterial prostatitis: Two different sub-categories according to a previous manipulation of the lower urinary tract. World J Urol 2006;24(1):45-50.
4. Skerk V, Krhen I, Schonwald S, Cajic V, Markovinovic L, Roglic S, Zekan S, Andracevic AT, Kruzic V. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;24(Suppl 1):S53-S56. (Pubitemid 39208862)
5. Roper WG. The etiology of benign prostatic hypertrophy. Med Hypotheses 1998;50(1):61-65.
6. Nickel JC. A new era in prostatitis research begins. Rev Urol 2000;2(1):16-18.
7. Vykhovanets EV, Resnick MI, MacLennan GT, Gupta S. Experimental rodent models of prostatitis: Limitations and potential. Prostate Cancer Prostatic Dis 2007;10(1):15-29.
8. Motrich RD, Maccioni M, Riera CM, Rivero VE. Autoimmune prostatitis: State of the art. Scand J Immunol 2007;66(2-3):217-227.
9. Rivero VE, Motrich RD, Maccioni M, Riera CM. Autoimmune etiology in chronic prostatitis syndrome: An advance in the understanding of this pathology. Crit Rev Immunol 2007;27(1):33-46.
10. Fritz JH, Le Bourhis L, Magalhaes JG, Philpott DJ. Innate immune recognition at the epithelial barrier drives adaptive immunity: APCs take the back seat. Trends Immunol 2008;29(1):41-49.
11. Philpott DJ, Girardin SE, Sansonetti PJ. Innate immune responses of epithelial cells following infection with bacterial pathogens. Curr Opin Immunol 2001;13(4):410-416.
12. Burgess AW. EGFR family: Structure physiology signalling and therapeutic targets. Growth Factors 2008;26(5):263-274.
13. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S, Seger R, Ratzkin BJ, Sela M, Yarden Y. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 1996;15(10):2452-2467. (Pubitemid 26151185)
14. Bhola NE, Grandis JR. Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer. Front Biosci 2008;13:1857-1865. (Pubitemid 351599738)
15. Li Z, Szabolcs M, Terwilliger JD, Efstratiadis A. Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene. Carcinogenesis 2006;27(5):1054-1067.
16. Sikes RA, Chung LW. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene. Cancer Res 1992;52(11):3174-3181.
17. Pastore S, Mascia F, Mariani V, Girolomoni G. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2008;128(6):1365-1374.
18. Festuccia C, Gravina GL, Biordi L, D'Ascenzo S, Dolo V, Ficorella C, Ricevuto E, Tombolini V. Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro. Prostate 2009;69(14):1529-1537.
19. Kambhampati S, Ray G, Sengupta K, Reddy VP, Banerjee SK, Van Veldhuizen PJ. Growth factors involved in prostate carcinogenesis. Front Biosci 2005;10:1355-1367.
20. Freeman MR. HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR? Cancer Cell 2004;6(5):427-428.
21. Hall SH, Hamil KG, French FS. Host defense proteins of the male reproductive tract. J Androl 2002;23(5):585-597.
22. Oberley RE, Goss KL, Dahmoush L, Ault KA, Crouch EC, Snyder JM. A role for surfactant protein D in innate immunity of the human prostate. Prostate 2005;65(3):241-251.
23. Oberley RE, Goss KL, Quintar AA, Maldonado CA, Snyder JM. Regulation of surfactant protein D in the rodent prostate. Reprod Biol Endocrinol 2007;5:42.
24. Quintar AA, Roth FD, De Paul AL, Aoki A, Maldonado CA. Toll-like receptor 4 in rat prostate: Modulation by testosterone and acute bacterial infection in epithelial and stromal cells. Biol Reprod 2006;75(5):664-672.
25. Aumuller G, Seitz J, Heyns W, Flickinger CJ. Intracellular localization of prostatic binding protein (PBP) in rat prostate by light and electron microscopic immunocytochemistry. Histochemistry 1982;76(4):497-516. (Pubitemid 13149064)
26. Mukherjee AB, Kundu GC, Mantile-Selvaggi G, Yuan CJ, Mandal AK, Chattopadhyay S, Zheng F, Pattabiraman N, Zhang Z. Uteroglobin: A novel cytokine? Cell Mol Life Sci 1999;55(5):771-787.
27. Roth FD, Quintar AA, Uribe Echevarria EM, Torres AI, Aoki A, Maldonado CA. Budesonide effects on Clara cell under normal and allergic inflammatory condition. Histochem Cell Biol 2007;127(1):55-68.
28. Elia J, Aoki A, Maldonado CA. Response of bronchiolar Clara cells induced by a domestic insecticide. Analysis of CC10 kDa protein content. Histochem Cell Biol 2000;113(2):125-133.
29. Quintar AA, Mukdsi JH, del Valle Bonaterra M, Aoki A, Maldonado CA, Perez Alzaa J. Increased expression of uteroglobin associated with tubal inflammation and ectopic pregnancy. Fertil Steril 2008;89(6):1613-1617.
30. Maccioni M, Cabezas LE, Rivero VE. Effect of prostatein, the major protein produced by the rat ventral prostate, on phagocytic cell functions. Am J Reprod Immunol 2003;50(6):473-480.
31. Maccioni M, Riera CM, Rivero VE. Identification of rat prostatic steroid binding protein (PSBP) as an immunosuppressive factor. J Reprod Immunol 2001;50(2):133-149. (Pubitemid 32396828)
32. Antonioli E, Della-Colleta HH, Carvalho HF. Smooth muscle cell behavior in the ventral prostate of castrated rats. J Androl 2004;25(1):50-56.
33. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002;8(9):2912-2923.
34. Penna G, Fibbi B, Amuchastegui S, Cossetti C, Aquilano F, Laverny G, Gacci M, Crescioli C, Maggi M, Adorini L. Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation. J Immunol 2009;182(7):4056-4064.
35. Kogan-Sakin I, Cohen M, Paland N, Madar S, Solomon H, Molchadsky A, Brosh R, Buganim Y, Goldfinger N, Klocker H, Schalken JA, Rotter V. Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis 2009;30(4):698-705.
36. Sutter E, Roulet FC. Staining Mycobacterium leprae in paraffin sections by the gomori methenamine-silver method. Stain Technol 1965;40:49-51.
37. Hammarsten P, Rudolfsson SH, Henriksson R, Wikstrom P, Bergh A. Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. Prostate 2007;67(6):573-581.
38. Fulmer BR, Turner TT. Effect of inflammation on prostatic protein synthesis and luminal secretion in vivo. J Urol 1999;162(1):248-253.
39. Gatti G, Rivero V, Motrich RD, Maccioni M. Prostate epithelial cells can act as early sensors of infection by up-regulating TLR4 expression and proinflammatory mediators upon LPS stimulation. J Leukoc Biol 2006;79(5):989-998.
40. Takeyama K, Mitsuzawa H, Shimizu T, Konishi M, Nishitani C, Sano H, Kunishima Y, Matsukawa M, Takahashi S, Shibata K, Tsukamoto T, Kuroki Y. Prostate cell lines secrete IL-8 in response to mycoplasma hominis through Toll-like receptor 2-mediated mechanism. Prostate 2006;66(4):386-391.
41. Gatti G, Quintar AA, Andreani V, Nicola JP, Maldonado CA, Masini-Repiso AM, Rivero VE, Maccioni M. Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer. Prostate 2009;69(13):1387-1397.
42. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000;173:27-38. (Pubitemid 30095208)
43. Kundu SD, Lee C, Billips BK, Habermacher GM, Zhang Q, Liu V, Wong LY, Klumpp DJ, Thumbikat P. The toll-like receptor pathway: A novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate 2008;68(2):223-229.
44. Mackern-Oberti JP, Maccioni M, Cuffini C, Gatti G, Rivero VE. Susceptibility of prostate epithelial cells to Chlamydia muridarum infection and their role in innate immunity by recruitment of intracellular Toll-like receptors 4 and 2 and MyD88 to the inclusion. Infect Immun 2006;74(12):6973- 6981.
45. Di JM, Pang J, Pu XY, Zhang Y, Liu XP, Fang YQ, Ruan XX, Gao X. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet 2009;192(2):60-67.
46. Elia J, Aoki A, Maldonado CA. Regulation of uteroglobin/Clara cell protein expression after acute lung exposure to an organo-phosphoreted insecticide. Histochem Cell Biol 2003;120(1):33-39.
47. Weinrauch Y, Zychlinsky A. The induction of apoptosis by bacterial pathogens. Ann Rev Microbiol 1999;53:155-187.
48. Kim JM, Eckmann L, Savidge TC, Lowe DC, Witthoft T, Kagnoff MF. Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 1998;102(10):1815-1823. (Pubitemid 28533828)
49. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun 2006;74(9):5106-5113.
50. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998;282(5393):1494-1497.
51. Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 2007;67(1):14-21.
52. Ma WW, Adjei AA. Novel agents on the horizon for cancer therapy. CA Cancer J Clin 2009;59(2):111-137.
53. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO J 1996;15(2):254-264.
54. Kim HG, Kassis J, Souto JC, Turner T, Wells A. EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol 1999;14(4):1175-1182. (Pubitemid 29447459)
55. Singer CA, Salinthone S, Baker KJ, Gerthoffer WT. Synthesis of immune modulators by smooth muscles. BioEssays 2004;26(6):646-655.
56. Niu Y, Xu Y, Zhang J, Bai J, Yang H, Ma T. Proliferation and differentiation of prostatic stromal cells. BJU Int 2001;87(4):386-393.
57. Danielpour D. Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. Eur J Cancer 2005;41(6):846-857. (Pubitemid 40461689)
58. Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD, Rowley DR. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 2008;72(1):205-213.